Aldo-keto reductases from the AKR1B subfamily: Retinoid specificity and control of cellular retinoic acid levels
- 1 March 2009
- journal article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 178 (1-3), 171-177
- https://doi.org/10.1016/j.cbi.2008.10.027
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Genomics of Smoking Exposure and Cessation: Lessons for Cancer Prevention and TreatmentCancer Prevention Research, 2008
- Structural basis for the high all-trans -retinaldehyde reductase activity of the tumor marker AKR1B10Proceedings of the National Academy of Sciences, 2007
- Aldo-Keto Reductases and Bioactivation/DetoxicationAnnual Review of Pharmacology and Toxicology, 2007
- Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoidsBiochemical Journal, 2006
- Biochemical Properties of Purified Human Retinol Dehydrogenase 12 (RDH12): Catalytic Efficiency toward Retinoids and C9 Aldehydes and Effects of Cellular Retinol-Binding Protein Type I (CRBPI) and Cellular Retinaldehyde-Binding Protein (CRALBP) on the Oxidation and Reduction of RetinoidsBiochemistry, 2005
- Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung CarcinomasClinical Cancer Research, 2005
- AKR1B10: A New Diagnostic Marker of Non–Small Cell Lung Carcinoma in SmokersClinical Cancer Research, 2005
- Sequence and expression levels in human tissues of a new member of the aldo-keto reductase familyBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Identification and Characterization of a Novel Human Aldose Reductase-like GenePublished by Elsevier BV ,1998
- A new nomenclature for the aldo-keto reductase superfamilyBiochemical Pharmacology, 1997